Myeloproliferative neoplasms overproduce mature cells from a clonal stem cell. JAK2 mutation is the key.
Polycythemia vera
JAK2 V617F in most patients. Pruritus after a hot bath, facial plethora, splenomegaly, thrombosis and low erythropoietin. Treat with phlebotomy and low-dose aspirin, and hydroxyurea for high-risk disease. Secondary polycythemia has high erythropoietin from hypoxia, renal tumors or testosterone.
Essential thrombocythemia
Sustained high platelet count with erythromelalgia, thrombosis and bleeding. JAK2, CALR or MPL mutations; hydroxyurea in high risk.
Primary myelofibrosis
Marrow fibrosis with teardrop cells, massive splenomegaly and extramedullary hematopoiesis. Dry tap on aspiration; ruxolitinib helps. Polycythemia vera can progress to this state or to acute leukemia.
Keep going in hematology and oncology
- Tumor markers, oncogenes and tumor suppressor genes
- Breast cancer: types, receptors, BRCA and screening
- Chemotherapy drugs: mechanisms and toxicities
- Paraneoplastic syndromes and oncologic emergencies